📈 Economy · Next Month

Novo Nordisk A/S (NASDAQ: NVO) beats Q2 2026 adjusted EPS consensus of approx. $0.82 per ADS on August 5, 2026

Hit ✦ AI-generated prediction Published on 12. July 2026 · Predicted for 5. August 2026 · Based on: Historical Cycle

Probability

71%

Novo Nordisk reports Q2 2026 on August 5. The ADS EPS consensus stands at approximately $0.82 per TipRanks. GLP-1 demand for semaglutide (Ozempic/Wegovy) remains structurally strong; Novo benefits from global capacity expansion and growing reimbursements in Europe and the US. Competitive pressure from Eli Lilly (tirzepatide) is priced in. Novo has beaten EPS consensus in each of the last four quarters. Beat probability: 71%. Currency risk (DKK/USD, EUR/USD) could dampen USD ADS translation. No Polymarket market available.

Data basis for this prediction

TipRanks: NVO Q2-2026-EPS-Konsens ~0,82 USD ADS, Ergebnisdatum 05.08.2026
Trading Economics EUR/USD: 1,1416 am 12.07.2026 (Währungsrisiko DKK-Konversion beachten)
Novo Nordisk IR: Semaglutid-Kapazitätsausbaupläne 2025–2026; Ozempic/Wegovy globale Marktdaten

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit

Novo Nordisk übertraf am 5. August 2026 den bereinigten EPS-Konsens deutlich: Tatsächliches adjustiertes EPS: 0,9527 USD je ADS vs. Konsens 0,7815 USD – ein Beat von ca. +22 %. Auch der Umsatz (12,1 Mrd. USD vs. 10,94 Mrd. erwartet) übertraf die Erwartungen. Treiber waren weiterhin starke GLP-1-Nachfrage (Ozempic/Wegovy) sowie ein Rekordstart der oralen Wegovy-Pille in den USA. Quellen: Investing.com Earnings Call Transcript (https://www.investing.com/news/transcripts/earnings-call-transcript-novo-nordisk-beats-q2-2026-estimates-shares-rise-premarket-93CH-4837532), MarketBeat (https://www.marketbeat.com/earnings/reports/2026-8-5-novo-nordisk-as-stock/), Globe and Mail (https://www.theglobeandmail.com/investing/markets/stocks/NVO-N/pressreleases/3670985/novo-nordisk-lifts-2026-outlook-after-strong-q2-adjusted-results/).

Related Predictions

📈 Economy ✦ AI

S&P 500 (SPX) closes above 7,500 on Friday, 13 November 2026 (confirmed via NYSE closing price or Bloomberg by 14 November 2026, 10:00 ET)

The S&P 500 dropped 4.36% on 5 November 2026 to 7,353.73 — its steepest one-day fall since April 2025 — triggered by an AI-chip selloff that wiped out the post-midterm rally (4 November: +1.72% to 7,698.80). Closing above 7,500 by 13 November requires a +2.0% recovery over 6 trading sessions. Goldman Sachs, Morgan Stanley and JPMorgan maintain year-end targets of 7,400–8,100; S&P 500 EPS growth consensus for 2026 stands at +14% YoY. Downside risks: elevated Treasury yields, persistent AI capex uncertainty. No specific Polymarket/Kalshi market found for this level.

62%

Next Week · Predicted for 13. Nov 2026

📈 Economy ✦ AI

US Consumer Price Index (headline CPI) for October 2026 exceeds 3.7 percent year-on-year — BLS release November 10, 2026, 8:30 AM ET (confirmed by BLS or Bloomberg by November 10, 2026, 10:00 AM ET)

The BLS releases October 2026 CPI on November 10, 2026 at 8:30 AM ET. Nowflation forecasts 3.82 percent YoY; the Cleveland Fed nowcasting model forecasts 3.74 percent — both clearly above the 3.7 percent threshold. The September 2026 prior reading was exactly 3.7 percent. Rising energy prices (Strait of Hormuz effectively closed since mid-October) and stable core inflation support a further uptick. An existing open platform prediction covers CPI >3.5%; this forecast raises the bar by 20 basis points. A miss would primarily require unexpected weakness in the energy component or food prices.

65%

Next Week · Predicted for 10. Nov 2026

📈 Economy ✦ AI

Gold (XAU/USD Spot) closes above $4,400 per ounce on 31 December 2026 (confirmed by Bloomberg or Kitco by 1 January 2027)

Gold (XAU/USD) rose to $4,134.83 on 5 November 2026 — driven by the Democratic midterm sweep (higher fiscal spending expected) and persistent inflation pressure. Kalshi's Dec 31 settlement market shows ~32% probability for a close above $4,400 and ~43% for above $4,300. Reaching the $4,400 year-end target would require a further ~6.4% gain. Supporting factors: fiscal expansion, geopolitical risks, structurally high central bank demand; UBS forecasts $4,800, JPMorgan $6,000 at year-end. Headwind: hawkish Fed stance (Polymarket: 72.5% for a December rate hike to 4.00–4.25%). Prediction anchors on Kalshi's ~32% for >$4,400.

32%

Next Year · Predicted for 31. Dec 2026